{
    "clinical_study": {
        "@rank": "21726", 
        "arm_group": [
            {
                "arm_group_label": "Estradiol and progesterone", 
                "arm_group_type": "Experimental", 
                "description": "Substituted FET GnRH-a, Estradiol, Progesterone"
            }, 
            {
                "arm_group_label": "Substituted FET cycle", 
                "arm_group_type": "Active Comparator", 
                "description": "substituted FET cycle Estradiol Progesterone"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to compare two FET protocols by modifying the substituted FET cycle\n      in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early\n      pregnancy loss.\n\n      Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early\n      pregnancy loss."
        }, 
        "brief_title": "Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregnancy Loss", 
            "Frozen Embryo Transfer"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Endometrial thickness \u2265 7 mm after stimulation\n\n          -  18-45 years\n\n          -  IVF/ICSI fertilisation\n\n          -  BMI > 18,5 <30 kg/m2\n\n          -  cycle length 25-34 days\n\n        Exclusion Criteria:\n\n          -  endometrial thickness < 7 mm or no triple layer endometrium and/or functional\n             follicles\n\n          -  Uterine abnormality\n\n          -  Chronic medical disease\n\n          -  oocyte donation cycles"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "722", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943812", 
            "org_study_id": "Skive-2013-BA"
        }, 
        "intervention": {
            "arm_group_label": [
                "Estradiol and progesterone", 
                "Substituted FET cycle"
            ], 
            "intervention_name": "Progesterone and estradiol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Estradiol", 
                "Polyestradiol phosphate", 
                "Progesterone", 
                "Estradiol valerate", 
                "Estradiol 3-benzoate", 
                "Estradiol 17 beta-cypionate", 
                "Deslorelin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 9, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Steen B Laursen, Ph.D.", 
                    "phone": "+45 76 24 50 20"
                }, 
                "facility": {
                    "address": {
                        "city": "Fredericia", 
                        "country": "Denmark", 
                        "zip": "7000"
                    }, 
                    "name": "IVF syd"
                }, 
                "investigator": {
                    "last_name": "Steen B Lauersen, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Birgit Alsbjerg, M.D.", 
                    "phone": "+45 78 44 57 60"
                }, 
                "facility": {
                    "address": {
                        "city": "Skive", 
                        "country": "Denmark", 
                        "zip": "7800"
                    }, 
                    "name": "Fertility Clinic Regional Hospital Skive"
                }, 
                "investigator": {
                    "last_name": "Birgit Alsbjerg, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation", 
        "other_outcome": {
            "measure": "Luteal progesterone levels", 
            "safety_issue": "No", 
            "time_frame": "7th week of gestation"
        }, 
        "overall_contact": {
            "email": "birgit.alsbjerg@viborg.rm.dk", 
            "last_name": "Birgit Alsbjerg, M.D.", 
            "phone": "+45 78 44 57 60"
        }, 
        "overall_contact_backup": {
            "email": "peter.humaidan@viborg.rm.dk", 
            "last_name": "Peter Humaidan, D.M.Sc.", 
            "phone": "+45 78 44 57 60"
        }, 
        "overall_official": {
            "affiliation": "Fertility Clinic Regional Hospital Skive", 
            "last_name": "Birgit Alsbjerg, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pregnancy loss rate", 
            "safety_issue": "No", 
            "time_frame": "Primary outcome is avaible after 12th  week of gestational."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943812"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Regionshospitalet Viborg, Skive", 
            "investigator_full_name": "Peter Humaidan", 
            "investigator_title": "D.M.Sc., M.D.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "14 days after embryo transfer."
        }, 
        "source": "Regionshospitalet Viborg, Skive", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peter Humaidan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}